Your browser is no longer supported. Please, upgrade your browser.
BIIB Biogen Inc. daily Stock Chart
Biogen Inc.
IndexS&P 500 P/E9.55 EPS (ttm)31.47 Insider Own0.10% Shs Outstand176.36M Perf Week1.27%
Market Cap53.00B Forward P/E9.25 EPS next Y32.49 Insider Trans-1.94% Shs Float172.97M Perf Month-5.41%
Income5.89B PEG3.02 EPS next Q7.76 Inst Own90.20% Short Float2.06% Perf Quarter3.32%
Sales14.38B P/S3.69 EPS this Y44.80% Inst Trans-0.07% Short Ratio1.71 Perf Half Y35.06%
Book/sh75.05 P/B4.00 EPS next Y-0.26% ROA21.90% Target Price335.17 Perf Year27.85%
Cash/sh25.38 P/C11.84 EPS next 5Y3.16% ROE43.50% 52W Range215.77 - 374.99 Perf YTD1.27%
Dividend- P/FCF8.07 EPS past 5Y20.50% ROI30.50% 52W High-19.86% Beta0.72
Dividend %- Quick Ratio1.60 Sales past 5Y8.20% Gross Margin86.40% 52W Low39.27% ATR20.30
Employees7400 Current Ratio1.70 Sales Q/Q4.10% Oper. Margin49.00% RSI (14)49.13 Volatility6.03% 7.37%
OptionableYes Debt/Eq0.45 EPS Q/Q66.70% Profit Margin41.00% Rel Volume0.68 Prev Close304.47
ShortableYes LT Debt/Eq0.33 EarningsApr 22 BMO Payout0.00% Avg Volume2.08M Price300.51
Recom2.60 SMA201.80% SMA50-1.99% SMA20011.36% Volume1,420,792 Change-1.30%
Mar-31-20Initiated Wolfe Research Peer Perform
Feb-27-20Initiated Barclays Overweight $389
Jan-27-20Upgrade Canaccord Genuity Hold → Buy $360
Dec-13-19Upgrade Credit Suisse Underperform → Neutral $260 → $300
Dec-02-19Downgrade Robert W. Baird Neutral → Underperform
Nov-12-19Initiated SunTrust Buy $337
Nov-01-19Downgrade Standpoint Research Buy → Hold
Oct-30-19Upgrade Bernstein Mkt Perform → Outperform
Oct-23-19Upgrade SVB Leerink Mkt Perform → Outperform $256 → $350
Oct-23-19Upgrade Guggenheim Neutral → Buy $256 → $365
Oct-23-19Reiterated H.C. Wainwright Buy $300 → $335
Oct-23-19Reiterated BofA/Merrill Underperform $200 → $235
Oct-17-19Resumed BofA/Merrill Underperform $200
Jun-28-19Downgrade Piper Jaffray Overweight → Neutral $280 → $250
Jun-05-19Upgrade Standpoint Research Hold → Buy
May-23-19Resumed Citigroup Neutral
May-23-19Initiated Wedbush Neutral
May-21-19Initiated Credit Suisse Underperform $198
Apr-10-19Resumed Raymond James Mkt Perform
Mar-25-19Reiterated H.C. Wainwright Buy $363 → $300
Apr-02-20 01:14PM  Berkshire's Unnoticed and Self-Beating Holdings
01:04PM  6 Health Care Companies Boosting Book Value
10:19AM  Vertex enters new era of leadership, drug development American City Business Journals
08:00AM  Biogen Enters The Coronavirus Drug Arena But Is BIIB Stock A Buy? Investor's Business Daily
07:30AM  Biogen Announces First Patient Treated With Higher Dose of SPINRAZA® (nusinersen) in Phase 2/3 DEVOTE Study GlobeNewswire
Mar-31-20 02:18PM  8 Experimental Coronavirus Treatments to Watch
Mar-30-20 07:00PM  Video: Top Guru Stocks Proving Resilience to Downturns +6.53%
06:47PM  US Indexes Close Higher Monday
10:53AM  Now Look Closely at the Stock Market Casualty List
10:14AM  The Zacks Analyst Blog Highlights: General Electric, Ford, 3M, Vir and Biogen Zacks
Mar-29-20 08:37AM  Relief Therapeutics, NeuroRx get FDA nod to start coronavirus trial Reuters
Mar-27-20 10:27AM  Coronavirus Means Fewer Stock Buybacks, Analyst Says. It Could Shake Up Biopharma.
10:20AM  Novartis wins key European recommendation for gene therapy Zolgensma Reuters
06:18AM  I Ran A Stock Scan For Earnings Growth And Biogen (NASDAQ:BIIB) Passed With Ease Simply Wall St.
Mar-26-20 06:58PM  Coronavirus update: Global case count 526,044 with 23,709 deaths, and jobless benefit seekers soar to historic levels MarketWatch +7.00%
03:47PM  UnitedHealth Group rolls out coronavirus testing kits Yahoo Finance Video
Mar-25-20 05:19PM  Warren Buffett's Predictable Stocks Outperforming on Market Weakness
10:28AM  S.F. biotech races potential COVID-19 drug toward clinical trial American City Business Journals
Mar-24-20 08:15AM  S&P 500 buybacks up 3.2% in Q4 2019; Full Year 2019 down 9.6% from record 2018, as companies brace for a more volatile 2020 PR Newswire
Mar-23-20 03:59PM  These 16 companies are working on coronavirus treatments or vaccines heres where things stand MarketWatch
Mar-20-20 12:57PM  5 Undervalued Stocks Trading Below Their Peter Lynch Value
Mar-19-20 10:51AM  12 Key Medical Meetings Canceled Or Postponed In The Face Of A Pandemic Benzinga
Mar-18-20 07:44PM  Coronavirus delays Biogen's Spinraza for some patients Reuters
05:49PM  Biotech Stock Roundup: MRNA & REGN Gain on Coronavirus Treatment Updates & More Zacks
Mar-17-20 02:57PM  Top Health Care Stocks for April 2020 Investopedia +8.38%
Mar-16-20 04:09PM  Biogen Foundation Commits $10 Million to Support COVID-19 Relief Efforts in the U.S. and Around the World GlobeNewswire -7.70%
09:31AM  Thinking about trading options or stock in Biogen, Clorox, Centene, Netflix, or Walmart? PR Newswire
Mar-15-20 09:55AM  The Week Ahead In Biotech: COVID-19 Updates, Tapering Earnings Flow, Eton's Seizure Drug Review Benzinga
Mar-14-20 08:00AM  Coronavirus Bear Market: All Stocks Are Under Quarantine, But Keep These Five Under Observation Investor's Business Daily
Mar-13-20 02:25PM  Were effectively hitting the pause button on the economy: Financial Analyst Yahoo Finance Video +13.51%
Mar-12-20 04:08PM  Small Biotech Surges On Biogen Deal To Develop A Coronavirus Drug Investor's Business Daily -8.62%
12:22PM  Boston hotel to close after outbreak at Biogen meeting American City Business Journals
10:48AM  Massachusetts Virus Outbreak Looks Like Italys Just Two Weeks Ago Bloomberg
10:25AM  The Zacks Analyst Blog Highlights: Amazon, IBM, Biogen, Newmont and Berkshire Hathaway Zacks
08:45AM  Vir Biotech to collaborate with Biogen for developing coronavirus treatment Reuters
08:25AM  Vir's stock gains 15% as it announces COVID-19 collaboration with Biogen MarketWatch
Mar-11-20 02:27PM  Top Analyst Reports for Amazon, IBM & Biogen Zacks
12:00PM  Coronavirus Advice: Cancel That Conference Bloomberg
11:22AM  Pharma M&A Has Slowed to a Crawl
10:00AM  Is Biogen Stock A Buy As It Takes Yet Another Run At Alzheimer's? Investor's Business Daily
Mar-10-20 06:35AM  Remote-work companies in Mass. see sales spike amid coronavirus concerns American City Business Journals
Mar-09-20 02:27PM  Trump, White House officials to discuss economic response to coronavirus: Rpt Yahoo Finance Video -6.53%
01:40PM  Todays Rout Looks a Bit Like the Financial Crisis. A Look at What They Have in Common and What They Dont.
01:37PM  Sangamo Therapeutics Shows Promise
12:10PM  Coronavirus Cases Swell In Massachusetts Following Biogen Meeting Investor's Business Daily
07:33AM  Biogen orders employees to work from home after employees at Boston meeting test positive for coronavirus MarketWatch
Mar-08-20 06:55PM  Biogen's coronavirus cases rise, implicating another Boston health care event American City Business Journals
03:18PM  Coronavirus update: 107,897 cases, 3,658 deaths; northern Italy under quarantine MarketWatch
11:39AM  Biogen orders all workers to work from home after employees at management meeting test positive for coronavirus MarketWatch
Mar-07-20 10:13AM  Is Biogen Inc. (BIIB) A Good Stock To Buy? Insider Monkey
09:00AM  Biogen Investors Face Next Test in Gamble on Alzheimers Disease Bloomberg
Mar-06-20 02:40PM  Stocks nosedive as coronavirus cases surpass 100K Yahoo Finance Video
12:11PM  Biogen Employees Test Positive For Coronavirus Following Boston Meeting Investor's Business Daily
11:01AM  Up to 175 people may have been exposed to coronavirus at Biogen meeting American City Business Journals
10:22AM  Three Biogen employees test positive for coronavirus Reuters
Mar-05-20 07:56PM  Biogen employees test positive for coronavirus after Boston meeting American City Business Journals
02:47PM  Quest Diagnostics launching coronavirus test Yahoo Finance Video
06:11AM  Dozens of backers chime in on $100M round for hearing loss startup American City Business Journals
Mar-04-20 09:55AM  Biotech Stock Roundup: GILD to Buy Forty Seven, Pipeline Updates From BIIB & More Zacks
Mar-03-20 03:03PM  Inovio plans human trials of coronavirus vaccine in April Yahoo Finance Video
Mar-02-20 03:11PM  This chart shows the market isnt rewarding financial engineering as buyback-oriented companies underperform MarketWatch +6.32%
02:34PM  Co-Diagnostics CEO on FDA's coronavirus policy changes Yahoo Finance Video
11:01AM  Alzheimer's target also could halt autism, Gladstone researchers show American City Business Journals
Mar-01-20 09:35AM  Should You Worry About Biogen Inc.'s (NASDAQ:BIIB) CEO Salary Level? Simply Wall St.
Feb-28-20 06:44PM  Biotechnology trade group taps former Biogen CEO as its coronavirus czar Reuters
05:27PM  Best Stock Traits to Look for as Markets Tumble
04:48PM  What A Biogen Deal Means For This Small Genetic Medicines Outlet Investor's Business Daily
11:08AM  Sangamo Stock Is Soaring on Plan to Collaborate With Biogen
07:28AM  The Daily Biotech Pulse: Sangamo In Genome-Editing Therapy Deal With Biogen, FDA Nod For Biohaven, Passage Bio IPO Benzinga
06:34AM  Biogen pays California biotech $350M upfront for Alzheimer's gene therapy American City Business Journals
Feb-27-20 04:06PM  Biogen and Sangamo Announce Global Collaboration to Develop Gene Regulation Therapies for Alzheimers, Parkinsons, Neuromuscular, and Other Neurological Diseases GlobeNewswire -5.30%
02:02PM  Biotech outlook amid race to develop coronavirus vaccine Yahoo Finance Video
Feb-20-20 09:34AM  Zacks Market Edge Highlights: Tesla, Micron, Biogen, GameStop and Maxar Technologies Zacks
Feb-18-20 03:32PM  16 Stocks Warren Buffett Is Buying and Selling Kiplinger
12:00PM  Wanna Be a Value Investor? Follow Buffett & Play 2 ETF Areas Zacks
10:00AM  Kroger Climbs on Warren Buffett Endorsement
06:13AM  Warren Buffett's Berkshire Hathaway Trims Apple Stake, Buys Into Kroger, Biogen Benzinga
Feb-17-20 06:48PM  Berkshire Hathaway Buys The Kroger Co, Occidental Petroleum Corp, Biogen Inc, Sells Wells Fargo ...
05:00AM  Buckingham's Bets in Biotech MoneyShow
Feb-14-20 07:58PM  Warren Buffett's Berkshire Hathaway Takes Stakes in Kroger, Biogen; Cuts Banks and Apple
06:13PM  Warren Buffett Buys Kroger, Biogen in 4th Quarter
05:28PM  Buffetts Berkshire Adds Biogen, Kroger Stakes; Stocks Climb Bloomberg
05:26PM  Warren Buffetts Berkshire Hathaway Bought Biogen, Kroger, Occidental Stock
05:11PM  Warren Buffett Made Some Surprising Buys And Sells For Berkshire Hathaway In Q4 Investor's Business Daily
04:55PM  Berkshire Hathaway starts position in Biogen, Kroger while trimming Travelers MarketWatch
09:02AM  Vertex Is the Top Big Biotech, According to Citi. 3 More Stocks It Says to Buy.
Feb-13-20 11:00AM  3 Undervalued 'Magic Formula' Stocks
Feb-11-20 10:33AM  These Pharma Giants Took A Hit On Two More Alzheimer's Failures Investor's Business Daily
09:12AM  Lilly Reports Disappointing Data on Alzheimer's Candidate Zacks
Feb-10-20 09:28AM  Alkermes (ALKS) to Report Q4 Earnings: What's in Store? Zacks
09:19AM  Lilly and Biogen Stocks Get Hit as Another Alzheimers Treatment Fails a Trial
08:01AM  Lilly's stock falls on failed Alzheimer's study MarketWatch
12:49AM  Roche and Eli Lilly drugs fail inherited Alzheimers trial Financial Times
Feb-08-20 07:00AM  Playing With Fire: Teslas Wild Week Gets Hearts Pumping on Wall Street Bloomberg
Feb-07-20 02:45PM  Top Stock Research Reports for Alphabet, Roche & Amgen Zacks
02:41PM  Edited Transcript of BIIB earnings conference call or presentation 30-Jan-20 1:00pm GMT Thomson Reuters StreetEvents
Feb-06-20 04:08PM  This Biotech Stock Fell, Then Rose, And Prodded Biogen Into A Two-Day Run Investor's Business Daily
11:53AM  Biogen Soars on Patent Win for MS Drug Tecfidera Over Mylan Zacks
09:15AM  S&P, NASDAQ Reach New Closing Highs on 3rd Day of Rally Zacks
06:37AM  Biogen shares rise as drugmaker avoids worst case scenario in patent dispute American City Business Journals
Biogen Inc. discovers, develops, manufactures, and delivers therapies for treating neurological and neurodegenerative diseases worldwide. The company offers TECFIDERA, AVONEX, PLEGRIDY, TYSABRI, and FAMPYRA for multiple sclerosis (MS); SPINRAZA for the treatment of spinal muscular atrophy; and FUMADERM to treat plaque psoriasis. It also provides BENEPALI, an etanercept biosimilar referencing ENBREL; IMRALDI, an adalimumab biosimilar referencing HUMIRA; and FLIXABI, an infliximab biosimilar referencing REMICADE. In addition, the company offers RITUXAN for the treatment of non-Hodgkin's lymphoma, chronic lymphocytic leukemia (CLL), rheumatoid arthritis, two forms of ANCA-associated vasculitis, and pemphigus vulgaris; RITUXAN HYCELA for non-Hodgkin's lymphoma and CLL; GAZYVA to treat CLL and follicular lymphoma; and OCREVUS for the treatment of relapsing MS and primary progressive MS; and other anti-CD20 therapies. Further, it is involved in developing Opicinumab, BIIB061, and BIIB091 for MS and neuroimmunology; Aducanumab, BAN2401, BIIB092, BIIB076, and BIIB080 to treat Alzheimer's disease and dementia; BIIB067, BIIB078, BIIB110, and BIIB100 to treat neuromuscular disorders; BIIB054 and BIIB094 for treating movement disorders; BIIB111 and BIIB112 for ophthalmology; Dapirolizumab pegol and BIIB059 to treat immunology and others; BIIB104 for neurocognitive disorders; BIIB093, TMS-007, and Natalizumab to treat acute neurology; BIIB074 and BIIB095 for pain; and SB11 biosimilar, which are under various stages of development. The company offers products through its sales force and marketing groups. Biogen Inc. has collaboration agreements with Genentech, Inc.; Ionis Pharmaceuticals, Inc.; Eisai Co., Ltd.; Alkermes Pharma Ireland Limited; Bristol-Myers Squibb Company; Acorda Therapeutics, Inc.; AbbVie Inc.; Skyhawk Therapeutics, Inc.; Neurimmune SubOne AG; and Sangamo Therapeutics Inc. The company was founded in 1978 and is headquartered in Cambridge, Massachusetts.
Insider Trading Relationship Date Transaction Cost #Shares Value ($) #Shares Total SEC Form 4
SHERWIN STEPHEN ADirectorMar 11Option Exercise58.4612,278717,77216,517Mar 12 06:56 PM
SHERWIN STEPHEN ADirectorMar 11Sale295.222,434718,57414,353Mar 12 06:56 PM
Vounatsos MichelChief Executive OfficerFeb 15Option Exercise0.004,847033,775Feb 19 06:20 PM
Sandrock AlfredEVP, Research & DevelopmentFeb 15Option Exercise0.001,213015,019Feb 19 06:17 PM
Galdes AlphonseEVP Pharmaceutical Oper & TechFeb 15Option Exercise0.0044102,672Feb 19 06:13 PM
ALEXANDER SUSAN HEVP Chief Legal Off & Corp SecFeb 15Option Exercise0.001,553037,261Feb 19 06:09 PM
Kramer RobinVP, Chief Accounting OfficerFeb 12Option Exercise0.001320282Feb 14 06:37 PM
Karp DanielEVP, Corporate DevelopmentFeb 12Option Exercise0.0096001,224Feb 14 06:36 PM
Guindo ChirfiEVP Glob. Prod Strat and CommFeb 12Option Exercise0.001,68004,375Feb 14 06:34 PM
Gregory GingerEVP, Human ResourcesFeb 12Option Exercise0.003,54705,021Feb 14 06:32 PM
Galdes AlphonseEVP Pharmaceutical Oper & TechFeb 12Option Exercise0.001,15402,337Feb 14 06:30 PM
CAPELLO JEFFREY DEVP & Chief Financial OfficerFeb 12Option Exercise0.001,91903,732Feb 14 06:27 PM
ALEXANDER SUSAN HEVP Chief Legal Off & Corp SecFeb 12Option Exercise0.005,967036,389Feb 14 06:25 PM
Vounatsos MichelChief Executive OfficerFeb 12Option Exercise0.0011,994031,483Feb 14 06:19 PM
Sandrock AlfredEVP, Research & DevelopmentFeb 12Option Exercise0.005,216014,509Feb 14 06:16 PM
CAPELLO JEFFREY DEVP & Chief Financial OfficerJan 02Option Exercise0.001,30202,219Jan 06 04:14 PM
Kramer RobinVP, Chief Accounting OfficerDec 03Option Exercise0.00840175Dec 05 04:24 PM
Posner Brian SDirectorDec 02Sale292.351,055308,4296,995Dec 03 05:58 PM
Guindo ChirfiEVP Glob. Prod Strat and CommDec 01Option Exercise0.0054302,855Dec 03 05:59 PM
Gregory GingerEVP, Human ResourcesAug 01Option Exercise0.0017902,295Aug 05 04:20 PM
Karp DanielEVP, Corporate DevelopmentJul 02Option Exercise0.001960322Jul 05 04:51 PM
Ehlers Michael DEVP, Research and DevelopmentJun 01Option Exercise0.001,12608,525Jun 04 04:56 PM
Vounatsos MichelChief Executive OfficerMay 02Option Exercise0.001,480022,487May 06 04:20 PM
DENNER ALEXANDER JDirectorMay 02Buy231.2438,0008,787,120643,000May 02 05:06 PM
Vounatsos MichelChief Executive OfficerMay 01Buy231.484,3511,007,16921,007May 02 04:30 PM
DENNER ALEXANDER JDirectorMay 01Buy229.4630,0006,883,800605,000May 02 05:06 PM
DENNER ALEXANDER JDirectorApr 30Buy229.2550,34211,540,904575,000May 02 05:06 PM